Publicaciones en colaboración con investigadores/as de Pierre and Marie Curie University (20)

2024

  1. Experimental Model of Biliary Tract Cancers: Subcutaneous Xenograft of Human Cell Lines in Immunodeficient Nude Mice

    Methods in molecular biology (Clifton, N.J.), Vol. 2769, pp. 87-98

2023

  1. Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance

    Nature Reviews Gastroenterology and Hepatology, Vol. 20, Núm. 7, pp. 462-480

  2. Intrinsic cancer cell phosphoinositide 3-kinase δ regulates fibrosis and vascular development in cholangiocarcinoma

    Liver International, Vol. 43, Núm. 12, pp. 2776-2793

2022

  1. Genetic alterations shaping tumor response to anti-EGFR therapies

    Drug Resistance Updates, Vol. 64

2021

  1. Cholangiopathy aggravation is caused by VDR ablation and alleviated by VDR-independent vitamin D signaling in ABCB4 knockout mice

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1867, Núm. 4

  2. Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment

    eLife, Vol. 10

  3. Zinc Finger E-Box Binding Homeobox 1 Promotes Cholangiocarcinoma Progression Through Tumor Dedifferentiation and Tumor–Stroma Paracrine Signaling

    Hepatology, Vol. 74, Núm. 6, pp. 3194-3212

2020

  1. Cancer-associated fibroblasts in cholangiocarcinoma

    Current Opinion in Gastroenterology, Vol. 36, Núm. 2, pp. 63-69

  2. Cold-atmospheric plasma induces tumor cell death in preclinical in vivo and in vitro models of human cholangiocarcinoma

    Cancers, Vol. 12, Núm. 5

  3. Photothermal Depletion of Cancer-Associated Fibroblasts Normalizes Tumor Stiffness in Desmoplastic Cholangiocarcinoma

    ACS Nano, Vol. 14, Núm. 5, pp. 5738-5753

2019

  1. Atmospheric pressure plasma jets applied to cancerology: Correlating electrical configuration with in vivo toxicity and therapeutic efficiency

    Journal of Physics D: Applied Physics, Vol. 52, Núm. 24

2018

  1. Role of ErbB/HER family of receptor tyrosine kinases in cholangiocyte biology

    Hepatology, Vol. 67, Núm. 2, pp. 762-773

  2. The IgF2/IR/IGF1R pathway in tumor cells and myofibroblasts mediates resistance to EGFR inhibition in cholangiocarcinoma

    Clinical Cancer Research, Vol. 24, Núm. 17, pp. 4282-4296

  3. Unveiling resistance mechanisms to EGFR inhibitors in cholangiocarcinoma

    Oncotarget

2017

  1. Epithelial-mesenchymal transition in cholangiocarcinoma: From clinical evidence to regulatory networks

    Journal of Hepatology, Vol. 66, Núm. 2, pp. 424-441

  2. Involvement of UDP-glucuronosyltransferases and sulfotransferases in the excretion and tissue distribution of resveratrol in mice

    Nutrients, Vol. 9, Núm. 12

  3. Role of the PDZ-scaffold protein NHERF1/EBP50 in cancer biology: From signaling regulation to clinical relevance

    Oncogene, Vol. 36, Núm. 22, pp. 3067-3079

2016

  1. Loss of ezrin in human intrahepatic cholangiocarcinoma is associated with ectopic expression of E-cadherin

    Histopathology, Vol. 69, Núm. 2, pp. 211-221

  2. Rac1 and EMT: A dangerous liaison?

    Translational Cancer Research

2015

  1. E-cadherin, guardian of liver physiology

    Clinics and Research in Hepatology and Gastroenterology, Vol. 39, Núm. 1, pp. 3-6